Syndax Pharmaceuticals Inc (SNDX)
Net Income Growth
31.29%
Quarterly · Period ending:
SNDX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported31.29%period ending
Latest reported31.29%period ending
SNDX Quarterly Net Income YoY % (-160337.52% → 31.29%)
Year-over-year change
High-resolution chart · PNG
SNDX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 31.2943% | |
| 49.7053% | |
| 27.7745% | |
| 27.8285% | |
| -5.5596% | |
| -17.1906% | |
| -29.9367% | |
| -64.4821% | |
| -52.5563% | |
| -76.0444% | |
| -84.9084% | |
| -44.468% | |
| -18.7453% | |
| -10.646% | |
| -140.7431% | |
| -71.5345% | |
| -63.9983% | |
| -34.0728% | |
| 571.0278% | |
| -0.9884% | |
| -34.275% | |
| -81.9572% | |
| -45.8786% | |
| -59.3031% | |
| -14.3872% | |
| -6.5306% | |
| 25.6782% | |
| 26.0065% | |
| 18.8819% | |
| 26.2707% | |
| 1.3976% | |
| -14.9125% | |
| -34.8193% | |
| -49.549% | |
| -76.6436% | |
| -0.795% | |
| -63.185% | |
| -25.5663% | |
| -105.4912% | |
| -93.6231% | |
| -34.5027% | |
| -110.3441% | |
| -48.3371% | |
| 0.5275% | |
| -38.4581% | |
| -22.1642% | |
| 18.0032% | |
| -58.8067% | |
| -17.7026% | |
| -253.562% | |
| -160,337.5232% |